Peterson B, Arzika AM, Amza A, Maliki R, Karamba AMankara, Moussa M, Kemago M, Liu Z, Houpt E, Liu J et al..  2024.  Assessment of spillover of antimicrobial resistance to untreated children 7 to 12 years old after mass drug administration of azithromycin for child survival in Niger: a secondary analysis of the MORDOR cluster-randomized trial.. Clin Infect Dis. 

O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IMamane, Beidi D, Galo N, Harouna N, Karamba AM et al..  2024.  Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.. N Engl J Med. 391(8):699-709.

Oldenburg CE, Ouattara M, Bountogo M, Boudo V, Ouedraogo T, Compaoré G, Dah C, Zakane A, Coulibaly B, Bagagnan C et al..  2024.  Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.. JAMA. 331(6):482-490.

Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.

Ousmane S, Kollo IA, Jambou R, Boubacar R, Arzika AM, Maliki R, Amza A, Liu Z, Lebas E, Colby E et al..  2023.  Wastewater-Based Surveillance of Antimicrobial Resistance in Niger: An Exploratory Study.. Am J Trop Med Hyg. 

Arzika AM, Maliki R, E Goodhew B, Rogier E, Priest JW, Lebas E, O'Brien KS, Le V, Oldenburg CE, Doan T et al..  2022.  Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.. Nat Commun. 13(1):976.

Oldenburg CE, Hinterwirth A, Dah C, Millogo O, Coulibaly B, Ouédraogo M, Sie A, Chen C, Zhong L, Ruder K et al..  2022.  Gut Microbiome among Children with Uncomplicated Severe Acute Malnutrition in a Randomized Controlled Trial of Azithromycin versus Amoxicillin.. Am J Trop Med Hyg. 

Oldenburg CE, Hinterwirth A, Ourohiré M, Dah C, Ouédraogo M, Sie A, Boudo V, Chen C, Ruder K, Zhong L et al..  2022.  Gut Resistome after Antibiotics among Children with Uncomplicated Severe Acute Malnutrition: A Randomized Controlled Trial.. Am J Trop Med Hyg. 107(1):59-64.

O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.

Arzika AM, Maliki R, Abdou A, Mankara AK, Harouna AN, Cook C, Hinterwirth A, Worden L, Zhong L, Chen C et al..  2021.  Gut resistome of preschool children after prolonged mass azithromycin distribution: a cluster-randomized trial.. Clin Infect Dis. 

Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.

Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.

Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, Kalua K, Mrango Z, Ray KJ, Cook C et al..  2018.  Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.. N Engl J Med. 378(17):1583-1592.

Doan T, Hinterwirth A, Arzika AM, Cotter SY, Ray KJ, O'Brien KS, Zhong L, Chow ED, Zhou Z, Cummings SL et al..  2018.  Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial.. Open Forum Infect Dis. 5(8):ofy182.